⌘K

Login Start Free

Home/Filings/4/0001468316-25-000013

4//SEC Filing

Raykov Rosty 4

Accession 0001468316-25-000013

CIK 0001211583other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 4:10 PM ET

Size

5.0 KB

Accession

0001468316-25-000013

Insider Transaction Report

Form 4

Period: 2025-11-05

FENNEC PHARMACEUTICALS INC.FENC

DirectorChief Executive Officer

Transactions

Sale
Common shares
2025-11-05$8.10/sh−10,000$81,000→ 82,318 total

Footnotes (1)

[F1]Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Documents

1 file

4
form4-11062025_041103.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001468316

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 4:10 PM ET
Size: 5.0 KB

View on SEC.gov